A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to measure the efficacy, safety, and tolerability of darigabat
(25 milligrams [mg] twice daily [BID]) compared with placebo in participants with panic
disorder.